192 related articles for article (PubMed ID: 7555467)
1. Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens.
Santucci L; Fiorucci S; Patoia L; Di Matteo FM; Brunori PM; Morelli A
Dig Dis Sci; 1995 Sep; 40(9):2074-80. PubMed ID: 7555467
[TBL] [Abstract][Full Text] [Related]
2. Pepsinogen A and C serum levels in relation to acute NSAID-associated mucosal lesions in healthy volunteers.
Aabakken L; Axelsson CK; Szecsi PB
Scand J Gastroenterol; 1993 Jun; 28(6):557-60. PubMed ID: 8322031
[TBL] [Abstract][Full Text] [Related]
3. Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease. A prospective study in healthy volunteers.
Thillainayagam AV; Tabaqchali S; Warrington SJ; Farthing MJ
Dig Dis Sci; 1994 May; 39(5):1085-9. PubMed ID: 8174421
[TBL] [Abstract][Full Text] [Related]
4. The effect of non-steroidal anti-inflammatory drugs and Helicobacter pylori infection on the gastric mucosa in children with upper gastrointestinal bleeding.
Boukthir S; Mazigh SM; Kalach N; Bouyahya O; Sammoud A
Pediatr Surg Int; 2010 Feb; 26(2):227-30. PubMed ID: 19823852
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study.
Lipscomb GR; Wallis N; Armstrong G; Rees WD
Br J Clin Pharmacol; 1998 Aug; 46(2):133-7. PubMed ID: 9723821
[TBL] [Abstract][Full Text] [Related]
6. Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial.
Laine L; Cominelli F; Sloane R; Casini-Raggi V; Marin-Sorensen M; Weinstein WM
Aliment Pharmacol Ther; 1995 Apr; 9(2):127-35. PubMed ID: 7605852
[TBL] [Abstract][Full Text] [Related]
7. Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: role of prostaglandins and inflammatory response.
Villegas I; La Casa C; de la Lastra CA; Motilva V; Herrerías JM; Martín MJ
Life Sci; 2004 Jan; 74(7):873-84. PubMed ID: 14659976
[TBL] [Abstract][Full Text] [Related]
8. Serum level of pepsinogen significantly associated with gastric distress induced by amino-bisphosphonates.
Shiraki M; Yamazaki Y; Kuroda T; Tanaka S; Miyata K
Osteoporos Int; 2011 Jun; 22(6):1717-23. PubMed ID: 21069296
[TBL] [Abstract][Full Text] [Related]
9. Comparison of endoscopic gastric mucosa features after administration of piroxicam to meloxicam and their correlation with dyspepsia symptoms in elderly patient with knee osteoarthritis.
Girawan D; Abdurachman SA; Djumhana A; Roslia J; Pramudiyo R
Acta Med Indones; 2004; 36(4):202-6. PubMed ID: 15673949
[TBL] [Abstract][Full Text] [Related]
10. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
;
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis.
Goggin PM; Collins DA; Jazrawi RP; Jackson PA; Corbishley CM; Bourke BE; Northfield TC
Gut; 1993 Dec; 34(12):1677-80. PubMed ID: 8282254
[TBL] [Abstract][Full Text] [Related]
12. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
al-Assi MT; Genta RM; Karttunen TJ; Graham DY
Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drugs associated with gastroduodenal injury and Helicobacter pylori.
Mizokami Y; Tamura K; Fukuda Y; Yamamoto I; Shimoyama T
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S109-12. PubMed ID: 7735925
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection and serum pepsinogen I concentration in peptic ulcer patients: effect of bacterial eradication.
Park SM; Park J; Chang SK; Yoo BC; Kim HJ
Korean J Intern Med; 1996 Jan; 11(1):1-8. PubMed ID: 8882471
[TBL] [Abstract][Full Text] [Related]
16. NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite.
Shiotani A; Yamaoka Y; El-Zimaity HM; Saeed MA; Qureshi WA; Graham DY
Dig Dis Sci; 2002 Jan; 47(1):38-43. PubMed ID: 11852880
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
[TBL] [Abstract][Full Text] [Related]
18. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
Feldman M; Cryer B; Mallat D; Go MF
Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
[TBL] [Abstract][Full Text] [Related]
19. The histopathology of non-steroidal anti-inflammatory drug induced gastroduodenal damage: correlation with Helicobacter pylori, ulcers, and haemorrhagic events.
Frezza M; Gorji N; Melato M
J Clin Pathol; 2001 Jul; 54(7):521-5. PubMed ID: 11429423
[TBL] [Abstract][Full Text] [Related]
20. Telomere length in non-neoplastic gastric mucosa and its relationship to H. pylori infection, degree of gastritis, and NSAID use.
Tahara T; Shibata T; Kawamura T; Ishizuka T; Okubo M; Nagasaka M; Nakagawa Y; Arisawa T; Ohmiya N; Hirata I
Clin Exp Med; 2016 Feb; 16(1):65-71. PubMed ID: 25563818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
